Abstract
Nano-Drug Delivery Systems have emerged as an effective means of targeting therapeutic agents such as drugs, peptides and proteins to various target sites. The unique advantages and potential targeting capability of this approach have claimed it as the drug delivery system of the future. Various analytical methodologies have been used for the evaluation of this delivery system both in vitro and in vivo. This review will attempt to describe the various in vitro methods used for this purpose, their importance and limitations. The in vitro methods include particle sizing, zeta potential, microscopy, Fourier transform infrared (FTIR) spectroscopy, differential scanning calorimetry, X-ray diffraction, in vitro release characteristics, determination of drug loading, encapsulation efficiency and loading efficiency. In vitro cell culture has also been utilized in cellular uptake, transmission electron microscopy, MTT assays, flow cytometry, and cellular transport studies. In summary, this in-depth review will provide the basic understanding, as well as the pros and cons of commonly used analytical methods currently utilized to evaluate this emerging drug delivery system.
Keywords: Nanoparticulate drug delivery systems, In vitro characterization, Size and surface charge, In vitro release, Cellular uptake, Cytotoxicity assay
Current Pharmaceutical Analysis
Title: Current Analytical Methods Used in the In Vitro Evaluation of Nano-Drug Delivery Systems
Volume: 5 Issue: 4
Author(s): Ankita A. Nagvekar, William J. Trickler and Alekha K. Dash
Affiliation:
Keywords: Nanoparticulate drug delivery systems, In vitro characterization, Size and surface charge, In vitro release, Cellular uptake, Cytotoxicity assay
Abstract: Nano-Drug Delivery Systems have emerged as an effective means of targeting therapeutic agents such as drugs, peptides and proteins to various target sites. The unique advantages and potential targeting capability of this approach have claimed it as the drug delivery system of the future. Various analytical methodologies have been used for the evaluation of this delivery system both in vitro and in vivo. This review will attempt to describe the various in vitro methods used for this purpose, their importance and limitations. The in vitro methods include particle sizing, zeta potential, microscopy, Fourier transform infrared (FTIR) spectroscopy, differential scanning calorimetry, X-ray diffraction, in vitro release characteristics, determination of drug loading, encapsulation efficiency and loading efficiency. In vitro cell culture has also been utilized in cellular uptake, transmission electron microscopy, MTT assays, flow cytometry, and cellular transport studies. In summary, this in-depth review will provide the basic understanding, as well as the pros and cons of commonly used analytical methods currently utilized to evaluate this emerging drug delivery system.
Export Options
About this article
Cite this article as:
Nagvekar A. Ankita, Trickler J. William and Dash K. Alekha, Current Analytical Methods Used in the In Vitro Evaluation of Nano-Drug Delivery Systems, Current Pharmaceutical Analysis 2009; 5 (4) . https://dx.doi.org/10.2174/157341209789649122
DOI https://dx.doi.org/10.2174/157341209789649122 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Intracellular Bioinorganic Chemistry and Cross Talk Among Different -Omics
Current Topics in Medicinal Chemistry Metabolic Syndrome, Thyroid Function and Autoimmunity - The PORMETS Study
Endocrine, Metabolic & Immune Disorders - Drug Targets The Roles of β-Carotene in Cardiomyocytes
Current Nutrition & Food Science Pertinence of Apoptosis Markers for the Improvement of In Vitro Fertilization (IVF)
Current Medicinal Chemistry Patient Centered Studies Focused on Type 2 Diabetes Management, Education, and Family Support: A Scoping Review
Current Diabetes Reviews Recent Advances in Antifungal Agents
Mini-Reviews in Medicinal Chemistry Antineoplastic Activity, Structural Modification, Synthesis and Structure-activity Relationship of Dammarane-type Ginsenosides: An Overview
Current Organic Chemistry Endothelial (Dys)Function in Lone Atrial Fibrillation
Current Pharmaceutical Design Branched-Chain Amino Acids and Pigment Epithelium-Derived Factor: Novel Therapeutic Agents for Hepatitis C Virus-Associated Insulin Resistance
Current Medicinal Chemistry The Potential Therapeutic Use of Stem Cells in Cartilage Repair
Current Stem Cell Research & Therapy Direct Interaction of Dietary Lipids Carried in Chylomicron Remnants with Cells of the Artery Wall: Implications for Atherosclerosis Development
Current Pharmaceutical Design Glycogen Metabolism and Brain Pathologies
Central Nervous System Agents in Medicinal Chemistry Chronic Exposure to Low-Level Cadmium in Diabetes: Role of Oxidative Stress and Comparison with Polychlorinated Biphenyls
Current Drug Targets Evaluation of Oxidative Status with Exhaled Breath 8-isoprostane Levels in Patients with Hyperthyroidism
Endocrine, Metabolic & Immune Disorders - Drug Targets Resveratrol and Stroke: from Chemistry to Medicine
Current Neurovascular Research Synthesis, Molecular Docking and PTP1B Inhibitory Activity of Functionalized 4,5-Dihydronaphthofurans and Dibenzofurans
Medicinal Chemistry Nuclear Factor Erythroid 2 - Related Factor 2 Signaling in Parkinson Disease: A Promising Multi Therapeutic Target Against Oxidative Stress, Neuroinflammation and Cell Death
CNS & Neurological Disorders - Drug Targets The Nociceptin/Orphanin FQ System as a Target for Treating Alcoholism
CNS & Neurological Disorders - Drug Targets Gene Transfer for Inborn Errors of Metabolism of the Liver: The Clinical Perspective
Current Pharmaceutical Design Pioglitazone, Bladder Cancer, and the Presumption of Innocence
Current Drug Safety